SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike stock is hitting 12-year lows amid concerns over weakening sportswear demand, internal leadership uncertainty, and stiff competition, fueling a heated community debate between value investors eyeing the dividend and bears warning of further downside. Traders are actively speculating on a potential turnaround or further capitulation while discussing the brand's relevance in the current retail climate.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is currently trending as investors debate the impact of recently issued convertible notes and the lack of an official earnings date, while bulls highlight heavy short interest and strong institutional ownership as catalysts for a potential squeeze. Community discourse remains sharply divided between those calling for transparency regarding revenue milestones and those accusing the company of dilution-heavy management.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is experiencing heightened volatility and bearish sentiment as investors weigh poor retail sales, competition from emerging lifestyle brands, and an upcoming leadership transition. While some in the community see the current valuation as a contrarian value opportunity, others remain skeptical about brand fatigue and the company's ability to navigate broader retail headwinds.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors rally around the company's aggressive patent litigation strategy and recent settlement developments, viewing it as a pivotal player in the high-demand AI memory sector. The community is intensely focused on potential upcoming licensing agreements with Micron and others, creating significant volatility and heavy trading volume as participants weigh the impact of these legal catalysts.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is currently trending following the recent FDA approval of its lead drug, Komzifti, with investors closely monitoring the upcoming commercial launch and potential for market share expansion in the NPM1-mutated AML space. The community is actively debating the stock's valuation relative to its cash position, while highlighting the drug's best-in-class safety profile and once-daily dosing as key competitive advantages over rival treatments.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is currently a focal point for investors as they weigh the potential value unlocking of its chip subsidiary, Kunlunxin, through a reported Hong Kong IPO, alongside its ongoing integration of AI models into major platforms. The stock is seeing heightened volatility as the community remains sharply divided between those betting on an AI-driven turnaround and bears citing macroeconomic concerns and long-term stagnation in Chinese equities.

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure analysis, reliability testing, tooling design, and real-time traceability system. Its manufacturing operations offer sensors, subsystems, customized optics, and optical modules and components. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet is currently drawing attention following a solid earnings report that featured a revenue beat and upward guidance, though the stock experienced some volatility as investors weighed these results against the broader optical sector's recent performance. The community is actively debating the disconnect between strong fundamental growth metrics and the stock's market reaction, while focusing on its critical role in AI optical packaging as a potential long-term growth driver.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is seeing intense investor focus as the market anticipates topline results from the Phase 3 LUCIDITY trial for avexitide in post-bariatric hypoglycemia, with recent analyst upgrades reflecting increased confidence in the company's metabolic pipeline. The community is actively debating the potential for a buyout and closely monitoring the stock for a breakout, driven by the combination of high short interest and expectations for positive trial data.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors react to EyePoint Pharmaceuticals' Duravyu failing its primary endpoint in a Phase 3 study, which the community views as a major competitive de-risking catalyst for Ocular's AXPAXLI. Shareholders are actively debating the implications for Ocular's regulatory pathway and its heightened appeal as a potential buyout candidate following this shift in the wet AMD landscape.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshire Hathaway is trending as investors debate the company's shift to a net-buying strategy after a prolonged period of hoarding cash, with community discourse divided between those trusting the transition under CEO Greg Abel and those criticizing the lack of innovation and perceived underperformance compared to the broader market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VIR reported 0.47 EPS and 238.95 revenue for Q2.
http://www.estimize.com/intro/vir?chart=historical&amp;metric_name=eps&amp;utm_content=VIR&amp;utm_me

Zapier

Vir Biotechnology Inc

 reported 0.47 EPS and 238.95 revenue for Q2.
